Publication Information

{'id': 'https://openalex.org/W2393769265', 'doi': None, 'title': 'Effects of edaravone on the level of serum tumor necrosis factor-α,IL-8 and hs-CRP in patients with acute cerebral infarction', 'display_name': 'Effects of edaravone on the level of serum tumor necrosis factor-α,IL-8 and hs-CRP in patients with acute cerebral infarction', 'publication_year': 2007, 'publication_date': '2007-01-01', 'ids': {'openalex': 'https://openalex.org/W2393769265', 'mag': '2393769265'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-JBJS200704011.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764662714', 'display_name': 'Nervous Diseases and Mental Health', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5032972303', 'display_name': 'MU Jun-sha', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'MU Jun-sha', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5032972303'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 63}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T14144', 'display_name': 'Chronic Cerebral Hypoperfusion-Related Neurodegenerative Diseases', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2808', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T14144', 'display_name': 'Chronic Cerebral Hypoperfusion-Related Neurodegenerative Diseases', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2808', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11266', 'display_name': 'Role of Microglia in Neurological Disorders', 'score': 0.991, 'subfield': {'id': 'https://openalex.org/subfields/2808', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13796', 'display_name': 'Neuroprotective Agents in Brain Injury and Diseases', 'score': 0.9864, 'subfield': {'id': 'https://openalex.org/subfields/2808', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/edaravone', 'display_name': 'Edaravone', 'score': 0.9377206}, {'id': 'https://openalex.org/keywords/cerebral-hypoperfusion', 'display_name': 'Cerebral Hypoperfusion', 'score': 0.474508}], 'concepts': [{'id': 'https://openalex.org/C2779554857', 'wikidata': 'https://www.wikidata.org/wiki/Q335099', 'display_name': 'Edaravone', 'level': 2, 'score': 0.9377206}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8674271}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.71811587}, {'id': 'https://openalex.org/C3020084786', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor α', 'level': 3, 'score': 0.6159601}, {'id': 'https://openalex.org/C503630168', 'wikidata': 'https://www.wikidata.org/wiki/Q178069', 'display_name': 'Necrosis', 'level': 2, 'score': 0.60863245}, {'id': 'https://openalex.org/C2779450755', 'wikidata': 'https://www.wikidata.org/wiki/Q1209150', 'display_name': 'Cerebral infarction', 'level': 3, 'score': 0.6025431}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5531046}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.5506338}, {'id': 'https://openalex.org/C2777798775', 'wikidata': 'https://www.wikidata.org/wiki/Q207550', 'display_name': 'Infarction', 'level': 3, 'score': 0.4452108}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.35095495}, {'id': 'https://openalex.org/C42219234', 'wikidata': 'https://www.wikidata.org/wiki/Q131130', 'display_name': 'Anesthesia', 'level': 1, 'score': 0.3217659}, {'id': 'https://openalex.org/C500558357', 'wikidata': 'https://www.wikidata.org/wiki/Q12152', 'display_name': 'Myocardial infarction', 'level': 2, 'score': 0.1974369}, {'id': 'https://openalex.org/C541997718', 'wikidata': 'https://www.wikidata.org/wiki/Q188151', 'display_name': 'Ischemia', 'level': 2, 'score': 0.19488579}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-JBJS200704011.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764662714', 'display_name': 'Nervous Diseases and Mental Health', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.77, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3198317694', 'https://openalex.org/W3030811574', 'https://openalex.org/W2393430644', 'https://openalex.org/W2389884130', 'https://openalex.org/W2389539763', 'https://openalex.org/W2385203432', 'https://openalex.org/W2380851505', 'https://openalex.org/W2376849463', 'https://openalex.org/W2375758563', 'https://openalex.org/W2374453878', 'https://openalex.org/W2372796540', 'https://openalex.org/W2371163762', 'https://openalex.org/W2368407809', 'https://openalex.org/W2367836453', 'https://openalex.org/W2364006088', 'https://openalex.org/W2361774717', 'https://openalex.org/W2358531542', 'https://openalex.org/W2356341780', 'https://openalex.org/W2354519186', 'https://openalex.org/W2351452109'], 'abstract_inverted_index': {'Objective': [0], 'To': [1], 'study': [2], 'effects': [3], 'of': [4, 22, 47, 63, 74, 109], 'edaravone': [5, 69], 'on': [6], 'serum': [7, 75, 116], 'tumor': [8, 76, 98, 117], 'necrosis': [9, 77, 99, 118], 'factor-α,IL-8': [10, 78, 100, 119], 'and': [11, 28, 34, 79, 84, 90, 95, 101, 120], 'hs-CRP': [12, 80, 102, 121], 'level': [13, 81, 103], 'in': [14, 39, 55, 122], 'patients': [15, 21, 38, 54, 123], 'with': [16, 124], 'acute': [17, 48, 64, 125], 'cerebral': [18, 23, 49, 65, 126], 'infarction.Methods': [19], '85': [20], 'infarction': [24, 50], 'were': [25, 42, 58], 'randomly': [26], 'divided': [27], 'assigned': [29], 'to': [30, 68], 'a': [31, 35], 'therapy': [32, 46, 56, 62], 'group': [33, 41, 57], 'control': [36, 40, 111], 'group.40': [37], 'treated': [43, 59], 'by': [44, 60], 'routine': [45, 61], 'two': [51, 70], 'weeks.Another': [52], '45': [53], 'infarction.in': [66], 'addition': [67], 'weeks.Recording': [71], 'the': [72, 110], 'changes': [73], 'before': [82], 'treatment': [83, 86], 'after': [85], '3': [87], 'd,7': [88], 'd': [89], '14': [91], 'd.Results': [92], 'After': [93], '3d,7d': [94], '14d': [96], 'treatment,serum': [97], 'decreased': [104], 'more': [105], 'dramatically,lower': [106], 'than': [107], 'that': [108], 'group.Conclusions': [112], 'Edaravone': [113], 'can': [114], 'lower': [115], 'infarction.': [127]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2393769265', 'counts_by_year': [], 'updated_date': '2024-09-26T12:50:51.909076', 'created_date': '2016-06-24'}